Literature DB >> 18262255

Variants of the basal vein of Rosenthal and perimesencephalic nonaneurysmal hemorrhage.

Thomas Daenekindt1, Guido Wilms, Vincent Thijs, Philippe Demaerel, Frank Van Calenbergh.   

Abstract

BACKGROUND: The cause of perimesencephalic nonaneurysmal SAH or PMH is not known. Earlier studies reported a possible contribution of a primitive variant of the BVR in the pathogenesis of PMH. We compared the variants of BVR in a case control study between patients with PMH and aneurysmal SAH by studying the venous phase of the DSA.
METHODS: Two observers reviewed the DSAs of 59 patients with PMH and 59 patients with aneurysmal SAH. The variants of BVR were classified into (1) normal continuous: BVR is continuous with the deep middle cerebral vein and drains mainly into the VG; (2) normal discontinuous: drainage anterior to uncal veins and posterior to the VG; and (3) primitive variant: drainage into veins other than the VG.
RESULTS: One hundred eighteen patients were enrolled, with a mean age of 49 +/- 12 years. There were 31 men and 28 women in each group. Patients with PMH were older than patients with aneurysmal SAH (52 vs 46, P = .01). Primitive variants were found in 21% on the left side and 29% on the right side (P = .27). There was no association between PMH and the presence of a primitive variant on the left (25% in PMH vs 19% in aneurysmal SAH, P = .65) or on the right side (31% in PMH vs 30% in aneurysmal SAH, P = .92) in univariate analysis. After correction for age and sex, variants on neither side were associated with PMH (OR: 1.4, P = .53 for left variants and 1.2, P = .67 for right variants).
CONCLUSIONS: In this large controlled study, we were unable to confirm a contribution of a primitive variant of the BVR in the pathogenesis of PMH.

Entities:  

Mesh:

Year:  2008        PMID: 18262255     DOI: 10.1016/j.surneu.2007.03.039

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  8 in total

1.  Concerning "Nonaneurysmal Perimesencephalic Hemorrhage Is Associated with Deep Cerebral Venous Drainage Anomalies: A Systematic Literature Review and Meta-Analysis".

Authors:  X Wu; R Liu; A Malhotra
Journal:  AJNR Am J Neuroradiol       Date:  2016-10-13       Impact factor: 3.825

2.  Perimesencephalic subarachnoid hemorrhage: when to stop imaging?

Authors:  Juan Pablo Cruz; Dipanka Sarma; Lyne Noel de Tilly
Journal:  Emerg Radiol       Date:  2011-03-01

Review 3.  Nonaneurysmal Perimesencephalic Hemorrhage Is Associated with Deep Cerebral Venous Drainage Anomalies: A Systematic Literature Review and Meta-Analysis.

Authors:  A Rouchaud; V T Lehman; M H Murad; A Burrows; H J Cloft; E P Lindell; D F Kallmes; W Brinjikji
Journal:  AJNR Am J Neuroradiol       Date:  2016-05-12       Impact factor: 3.825

4.  Nonaneurysmal subarachnoid hemorrhage: an update.

Authors:  Young Woo Kim; Matthew F Lawson; Brian L Hoh
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

5.  Benefit of second catheter angiography in patients with nontraumatic subarachnoidal hemorrhage.

Authors:  A Ringelstein; O Mueller; S L Goericke; C Moenninghoff; U Sure; I Wanke; M Forsting; M Schlamann
Journal:  Clin Neuroradiol       Date:  2013-11-28       Impact factor: 3.649

6.  Occurrence of perimesencephalic subarachnoid hemorrhage during pregnancy.

Authors:  Karen G Hirsch; Michael T Froehler; Judy Huang; Wendy C Ziai
Journal:  Neurocrit Care       Date:  2009-01-30       Impact factor: 3.210

7.  [Reangiography after perimesencephalic subarachnoid hemorrhage].

Authors:  A Ringelstein; O Mueller; O Timochenko; C Moenninghoff; U Sure; M Forsting; M Schlamann
Journal:  Nervenarzt       Date:  2013-06       Impact factor: 1.214

8.  Management of Spontaneous Subarachnoid Hemorrhage Patients with Negative Initial Digital Subtraction Angiogram Findings: Conservative or Aggressive?

Authors:  Liang Xu; Yuanjian Fang; Xudan Shi; Xianyi Chen; Jun Yu; Zeyu Sun; Jianmin Zhang; Jing Xu
Journal:  Biomed Res Int       Date:  2017-05-02       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.